Literature DB >> 8005591

PME of Unverricht-Lundborg type in the Mediterranean region: linkage and linkage disequilibrium confirm the assignment to the EPM1 locus.

A E Lehesjoki1, C A Tassinari, G Avanzini, R Michelucci, S Franceschetti, A Antonelli, G Rubboli, A de la Chapelle.   

Abstract

Seven phenotypically homogeneous Mediterranean myoclonus families were studied using DNA markers from the genetically defined EPM1 region on chromosome 21. No recombinations between the disease phenotype and the markers studied were detected. Within the EPM1 region, the highest lod score value of 5.07 (at theta = 0.00) was reached at locus PFKL. Significant allelic association (P = 0.02) between the disease mutation and PFKL was detected suggesting a founder effect in Mediterranean myoclonus. However, haplotype data using four marker loci residing within 300 kb of each other and of EPM1 suggest the occurrence of more than one mutation. The data are compatible with Mediterranean myoclonus being caused by mutations in the EPM1 gene and strengthen the concept that a large subset of progressive myoclonus epilepsies conforms with Unverricht-Lundborg disease and that this subset is an etiologically homogeneous entity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005591     DOI: 10.1007/BF00201568

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Classification of progressive myoclonus epilepsies and related disorders. Marseille Consensus Group.

Authors: 
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

2.  A polymorphic DNA sequence from the terminal part of chromosome 21q [D21S154].

Authors:  F Rouyer; A de la Chapelle; J Weissenbach
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

Review 3.  The Ramsay Hunt syndrome is a useful clinical entity.

Authors:  C D Marsden; J A Obeso
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

4.  Psychological findings in progressive myoclonus epilepsy without Lafora bodies.

Authors:  M Koskiniemi
Journal:  Epilepsia       Date:  1974-12       Impact factor: 5.864

5.  [Electroencephalographic study of myoclonic cerebellar dyssynergia with epilepsy (Ramsay-Hunt syndrome)].

Authors:  C A Tassinari; M Bureau-Paillas; E Grasso; J Roger
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1974 Jul-Sep

6.  Progressive myoclonus epilepsy. Electroencephalographical findings.

Authors:  M Koskiniemi; E Toivakka; M Donner
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

7.  Progressive myoclonus epilepsy of Unverricht-Lundborg type: a clinical and molecular genetic study of a family from the United States with four affected sibs.

Authors:  A E Lehesjoki; R Eldridge; J Eldridge; B J Wilder; A de la Chapelle
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Linkage mapping of the cystathionine beta-synthase (CBS) gene on human chromosome 21 using a DNA polymorphism in the 3' untranslated region.

Authors:  D Avramopoulos; T Cox; J P Kraus; A Chakravarti; S E Antonarakis
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland.

Authors:  J Hästbacka; A de la Chapelle; I Kaitila; P Sistonen; A Weaver; E Lander
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

View more
  1 in total

1.  Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation.

Authors:  Giovanni Coppola; Chiara Criscuolo; Giuseppe De Michele; Salvatore Striano; Fabrizio Barbieri; Pasquale Striano; Anna Perretti; Lucio Santoro; Vincenzo Brescia Morra; Francesco Saccà; Valentina Scarano; Adamo P D'Adamo; Sandro Banfi; Paolo Gasparini; Filippo M Santorelli; Anna E Lehesjoki; Alessandro Filla
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.